Presentation TCT 2017 VALIDATE-SWEDEHEART STEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With STEMI Presenter: Y. S. Chandrashekhar, David J. Moliterno, Stefan K. James October 31, 2017
Presentation TCT 2017 TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD October 31, 2017
Presentation TCT 2017 DEBATE-SFA: A Randomized Trial of a BMS With or Without Cilostazol vs a DES in Patients With Femoropopliteal Disease Presenter: David P. Faxon, Joseph A. Hill, Yusuke Miyashita October 31, 2017
Presentation TCT 2017 RECOVERY: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating vs a Polymer-Free Metallic DES in Patients With Coronary Artery Disease Presenter: David P. Faxon, Joseph A. Hill, Ling Tao October 31, 2017
Presentation TCT 2017 ABSORB 3-Year Meta-analysis: 3-Year Outcomes of a Bioresorbable Scaffold Compared to a Metallic DES From an Individual Patient Data Meta-analysis of Four Randomized Trials Presenter: David P. Faxon, Joseph A. Hill, Ziad A. Ali October 31, 2017
Presentation TCT 2017 PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen October 31, 2017
Presentation TCT 2017 ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Gregg W. Stone October 31, 2017
Presentation TCT 2017 ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Stephen G. Ellis October 31, 2017
Presentation TCT 2017 Featured Lecture: The NIH Mission to Enhance DIVERSITY in Clinical Trials, Education, and the Workforce Presenter: Roxana Mehran, George A. Mensah October 31, 2017
Presentation TCT 2017 Perspectives on the Feasibiity and Trustworthiness of Large, Simple Trials: From TASTE to ADAPTABLE Presenter: Robert A. Harrington, Sanjay Kaul, Schuyler Jones October 30, 2017
News Conference News TCT 2017 No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS Michael O'Riordan October 30, 2017
Presentation TCT 2017 Risk Score Development, Validation, Precision, Discrimination, and Utility Presenter: Robert A. Harrington, Sanjay Kaul, Davide Capodanno October 30, 2017
News Conference News TCT 2017 DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis Todd Neale October 30, 2017
Presentation TCT 2017 Do Patients Really Do Better When Their Cardiologists Are Away at Conferences? Embedding Controls in Observational Studies Presenter: Robert A. Harrington, Sanjay Kaul, Robert W. Yeh October 30, 2017
Presentation TCT 2017 The NOTION 2 Low-risk Trial in Younger Patients Presenter: Lars Sondergaard October 30, 2017
Presentation TCT 2017 Assessment of the Quality and Reliability of Meta-analysis (Summary Level, Network, and Individual Patient Data-Based) Presenter: Robert A. Harrington, Sanjay Kaul, Giuseppe Biondi-Zoccai October 30, 2017
Presentation TCT 2017 Natures Randomized Trials: Natural Experiments, Instrumental Variables, and Mendelian Randomization (Strengths and Limitations) Presenter: Robert A. Harrington, Sanjay Kaul, Robert W. Yeh October 30, 2017